These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 373096)

  • 1. Prolongation of rat cardiac allograft survival by donor pretreatment. Impact of dose and timing of drug administration.
    Soots A; Häyry P
    Scand J Thorac Cardiovasc Surg; 1979; 13(1):83-6. PubMed ID: 373096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of rat cardiac allograft survival by donor pretreatment. Screening of antineoplastic drugs.
    Soots A; Häyry P
    Transplantation; 1978 May; 25(5):259-64. PubMed ID: 349802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide.
    Lasek W; Jakóbisiak M; Płodzisewska M; Szczytnicki W; Górecki D
    Immunol Lett; 1988 Apr; 17(4):357-60. PubMed ID: 3286491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication sheets for patients. Oral chemotherapy.
    Clin J Oncol Nurs; 2003; 7(6 Suppl):40-72. PubMed ID: 14705499
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged cardiac xenograft survival is induced by intrathymic splenocyte injection.
    Sheffield CD; Hadley GA; Dirden BM; Bartlett ST
    J Surg Res; 1994 Jul; 57(1):55-9. PubMed ID: 8041149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Enhancement by combined immunosuppressant treatment of the recipient.
    Kahn DR; Forrest DE; Otto DA
    Transplantation; 1991 Mar; 51(3):697-700. PubMed ID: 2006528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival.
    Kamei T; Callery MP; Flye MW
    Surgery; 1990 Aug; 108(2):415-21; discussion 421-2. PubMed ID: 2382235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1994 Aug; 7(5):315-8. PubMed ID: 7527637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between pancreas and heart allotransplantation after administration of donor-specific antigen and cyclosporine.
    Cooke JC; McBride JL; Schulak JA
    Transplantation; 1989 Jul; 48(1):15-9. PubMed ID: 2473549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.